Students with a first class honours (or equivalent) BSc degree may register directly in a Doctoral program. Students registering in a Masters program are encouraged to transfer directly into a Doctoral program after one year if their course work is of sufficient standard and if transfer is approved by their thesis advisory committee.
Given the Terry Fox Laboratory’s translational activities as well as a strong foundation in basic research relevant to cancer, individuals with an interest or background in medicine can also pursue MSc or PhD degrees, including applicants interested in the combined MD/PhD program.
To facilitate this, students and postdoctoral fellows present their research once a year in a weekly Work-in-Progress seminar within the Terry Fox Laboratory, and often in other seminar series, depending on the graduate program. In addition, a seminar course is part of the academic requirements of most graduate programs.
Students also play an active role in various small journal clubs and group meetings. Opportunities exist to attend many seminars by outstanding scientific visitors to Vancouver, including a weekly seminar series on cancer-related basic and clinical research topics.
More advanced students are also encouraged to attend and expected to present their own findings at international scientific meetings for which financial support is available.
Fees and Financial Support
These could include various scholarships or awards (from UBC, the Canadian Institutes of Health Research – CIHR, or the Natural Sciences and Engineering Research Council – NSERC), the supervisor’s research grant, or partial teaching assistantships. MSc students are normally supported for up to two years, and PhD students for up to 5 years, assuming satisfactory progress in the training program. Individuals with MDs who are pursuing PhD degrees are generally supported at a higher level, depending on their previous extent of training.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.